Showing results (71-80 of 128) with videos related to
Sort By:
Pageof 13
Open Forum Infectious Diseases|April 6, 2019
Identification of 19 Novel Hepatitis C Virus Subtypes-Further Expanding HCV ClassificationCharlotte Hedskog, Bandita Parhy, Silvia Chang, et al.Journal of Hepatology|February 1, 2014
Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trialJean Marc Perarnau, Amélie Le Gouge, Charlotte Nicolas, et al.BMJ Open|December 26, 2019
Stress management in obesity during a thermal spa residential programme (ObesiStress): protocol for a randomised controlled trial studyFrédéric Dutheil, Elodie Chaplais, Audrey Vilmant, et al.ESMO Open|November 7, 2017
Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinomaPhilippe Merle, Philippe Camus, Armand Abergel, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 8, 2021
Microsporidiosis after liver transplantation: A French nationwide retrospective studyJérôme Dumortier, Sylvie Radenne, Nassim Kamar, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2020
Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studiesBetty B Yao, Linda M Fredrick, Gretja Schnell, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2020
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosisArmand Abergel, Tarik Asselah, Arianne Mallat, et al.Journal of Hepatology|November 5, 2019
Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trialRobert S Brown, Maria Buti, Lino Rodrigues, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2025
Features and Outcomes of 280 Patients With Idiosyncratic Drug-induced Liver Injury: The REFHEPS Prospective StudyLucy Meunier, Bénédicte Delire, Eleonora De Martin, et al.Open Forum Infectious Diseases|November 9, 2023
Herpes Simplex Virus Hepatitis in Patients Requiring Intensive Care Unit Admission: A Retrospective, Multicenter, Observational StudyThomas Frapard, Giuliana Amaddeo, Maxens Decavele, et al.Pageof 13